Finesse F3 by Seattle Chronic Seeds
Ruderalis × Indica × Sativa
Finesse F3, developed by Seattle Chronic Seeds, is an innovative hybrid that combines ruderalis, indica, and sativa genetics. This well-balanced strain is known for its auto-flowering traits, robust genetics, and distinct sensory profile, making it a versatile option for various consumers.
Appearance
Finesse F3 buds are dense and compact, often covered in a thick layer of trichomes. They display vibrant green hues accented by purple and orange pistils, reflecting its diverse genetic background. The symmetrical and resinous appearance is often indicative of high cannabinoid content.
Aroma & Flavor
The aroma of Finesse F3 is complex, featuring earthy, spicy, and subtly sweet notes with hints of pine and floral undertones. Its flavor profile mirrors this complexity, offering an initial earthy taste with a slight charred note, followed by a delicate sweetness and botanical spice notes.
Effects
Consumers report that Finesse F3 delivers a nuanced spectrum of effects, blending relaxation with a gentle cerebral uplift. It can induce euphoria and increased sociability, followed by profound body relaxation, making it suitable for both daytime activities and evening use.
Terpenes & Cannabinoids
This strain typically contains THC levels between 15-20% and modest amounts of CBD. Its terpene profile includes myrcene, caryophyllene, and limonene, which contribute to its aroma, flavor, and potential therapeutic effects through an 'entourage effect'.
Growing
The inclusion of ruderalis genetics provides Finesse F3 with auto-flowering characteristics, leading to a quicker life cycle and potential for multiple harvests. Strains from Seattle Chronic Seeds are noted for yield improvements of 15-20% compared to conventional hybrids.
Origins & Lineage
Finesse F3 was developed by Seattle Chronic Seeds, a breeder known for pushing cultivation boundaries. It is a hybrid cross incorporating ruderalis for auto-flowering traits, indica for relaxation, and sativa for cerebral uplift, aiming for a balanced genetic contribution from each.